BARCELONA (Reuters) - Though speculation is rife of a new Pfizer bid, AstraZeneca's chief executive is not holed up with advisers in London or New York. Instead, he has spent the last three days immersed in heart science in Barcelona.

from Reuters: Business News http://ift.tt/1nRRBbs
via IFTTT
from Reuters: Business News http://ift.tt/1nRRBbs
via IFTTT
No hay comentarios:
Publicar un comentario